Armistice Capital »

Bio-path Hldgs shares owned by Armistice Capital

Quarter-by-quarter ownership of Bio-path Hldgs (BPTH) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Bio-path Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Bio-path Hldgs held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-path Hldgs by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $194k 97k 2.00

More positions owned by Armistice Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Incyte Corporation (INCY)
Immunovant (IMVT)
Travere Therapeutics (TVTX)
Agios Pharmaceuticals (AGIO)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Argenx Se Sponsored Adr (ARGX)
Inari Medical Ord (NARI)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Dentsply Sirona (XRAY)
Novo-nordisk A S Adr (NVO)

View all positions for Armistice Capital

Top funds holding Bio-path Hldgs

Apollon Wealth Management
Geode Capital Management
Vanguard Group
Virtu Financial
Citadel Advisors
Tower Research Capital
UBS Group
BlackRock
Bank of America Corporation
Group One Trading
EverSource Wealth Advisors
Global Retirement Partners
Hanson McClain Advisors

View all funds holding Bio-path Hldgs